EUnetHTA JA Methodology Archive (2010 – 2012)
Methodological guidelines for rapid relative effectiveness assessment (REA) of Pharmaceuticals
- Clinical endpoints
- Composite endpoints
- Surrogate endpoints
- Safety
- Health-related quality of life
- Criteria for the choice of the most appropriate comparator(s)
- Direct and indirect comparison
- Internal validity
- Applicability of evidence in the context of a relative effectiveness assessment
Please note that the updated versions of these Guidelines can be found under JA2 Guidelines here.
